Pharmaceutical Grade Lactose Market

Pharmaceutical Grade Lactose Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
Frequently asked questions about this report

The pharmaceutical grade lactose market is expected to reach US$ 3.29 Billion by 2032.

The pharmaceutical grade lactose market is expected grow at a CAGR of 5.6% between 2023 to 2032.

The pharmaceutical grade lactose market was estimated to be US$ 1.91 Billion in 2022.

The global pharmaceutical grade lactose market is being driven by several key factors including growing demand for lactose as an excipient in tablet and capsule formulations, the pharmaceutical industry's expanding manufacturing activities worldwide and rising prevalence of chronic diseases.

The United States, in particular, holds a substantial share in the market due to the presence of major pharmaceutical companies and contract manufacturing organizations (CMOs).

Agropur Inc. (Canada), BASF SE (Germany), DFE Pharma (Netherlands), DMV Fonterra Excipients (Netherlands), Glanbia plc (Ireland), Hilmar Ingredients (United States), Kerry Group (Ireland), Lactose (India) Limited (India), Merck KGaA (Germany), Meggle Pharma (Germany), Roquette Frères (France), Sterling Biotech Group (India), Taisho Pharmaceutical Co., Ltd. (Japan), The Lubrizol Corporation (United States), Zeria Pharmaceutical Co., Ltd. (Japan) among others, are the key players in this market.

Crystalline lactose is the largest type of lactose in the market. Crystalline lactose is favored in the pharmaceutical industry due to its excellent compressibility and flowability properties, making it highly suitable for tablet manufacturing.